5-MBPB
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • 1-(1-benzofuran-5-yl)-N-methylbutan-2-amine
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC13H17NO
Molar mass203.28 g/mol (freebase) 239.78 g/mol (hydrochloride) g·mol−1
3D model (JSmol)
  • CCC(CC1=CC2=C(OC=C2)C=C1)NC
  • InChI=1S/C13H17NO/c1-3-12(14-2)9-10-4-5-13-11(8-10)6-7-15-13/h4-8,12,14H,3,9H2,1-2H3
  • Key:CTEZPBCLIKEASW-UHFFFAOYSA-N

5-MBPB (also known as 5-MPBP and 5-MABB) is an amphetamine derivative which is structurally related to MDMA and has been sold as a designer drug. It can be described as the benzofuran-5-yl analogue of MBDB or the butanamine homologue of 5-MAPB, and is also a structural isomer of 5-EAPB and 6-EAPB. Anecdotal reports suggest this compound has been sold as a designer drug in various European countries since early 2015, but the first definitive identification was made in December 2015 by a forensic laboratory in Slovenia.[1]

5-MBPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor.[2]

References

  1. ^ European Monitoring Center for Drugs and Drug Addiction – Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA
  2. ^ US patent 7045545, Karin Briner et al, "Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists", published 2000-01-19, issued 2006-16-03 
Categories